Study to Investigate the Effect of Balovaptan on the QTC Interval in Healthy Subjects

Clinical trial NCT03808298 · COMPLETED

Trial details

NCT number: NCT03808298
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2019-02-07
Primary completion: 2019-06-14
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.